Because methylation of p53 serves as a protective mechanism to inhibit apoptotic cell death, targeting the methylation of p53 may prove to be a therapeutic strategy to limit cell loss in diseased states such as heart failure [103]. The gene discussed is TP53; the disease is heart failure.